Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFFIRM-AHF
2016-001467-36Phase 4Completed
- Sponsor
- CSL Vifor
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) and heart failure (HF) comparing Ferric carboxymaltose with Placebo (2 arms). Started Nov 2016; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)heart failure (HF)
Beyond the preview
Go deeper on 2016-001467-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001467-36.